By Kenrick Cai (Reuters) – Alphabet’s Google on Thursday announced a set of features that incorporated Gemini, its artificial intelligence chatbot, into its suite of
Category: Business
UK finance firms told to beef up buffers against CrowdStrike-like events
LONDON (Reuters) – Financial companies in Britain must prepare to ensure they can deliver business services in “severe but plausible” scenarios, such as a global
AMD shares slump as forecast disappoints AI-focused investors
(Reuters) – Advanced Micro Devices shares fell 8% on Wednesday after the chip company’s revenue forecast failed to impress investors looking for a bigger windfall
Top Chinese airlines’ profits fall as flagging economy pressures fares
By Lisa Barrington and Sophie Yu SEOUL/BEIJING (Reuters) – China’s top three state-owned airlines reported profit declines in the third quarter despite record summer passenger
Alphabet says Spotify, Paramount sign to use new cloud chip
By Stephen Nellis (Reuters) – Google Cloud, a unit of Alphabet Inc, said on Wednesday that Spotify Technology and Paramount Global are using a new
Exclusive-OpenAI builds first chip with Broadcom and TSMC, scales back foundry ambition
By Krystal Hu, Fanny Potkin and Stephen Nellis (Reuters) – OpenAI is working with Broadcom and TSMC to build its first in-house chip designed to
Microsoft’s AI demand under scrutiny as investors seek payday
By Aditya Soni (Reuters) – Microsoft is expected to report its slowest quarterly revenue growth in a year on Wednesday, while investors await signs of
Google to develop AI that takes over computers, The Information reports
(Reuters) – Alphabet’s Google is developing artificial intelligence technology that takes over a web browser to complete tasks such as research and shopping, The Information
Intel to invest more than $28 billion to build two chip factories in Ohio
(Reuters) -Intel said on Friday it would invest more than $28 billion to construct two new chip factories in Licking County, Ohio, as the company
Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
(Reuters) – Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm